DNA Structure, Replication, And Repair — Molecular Biology – DNA Structure, Replication, And Repair

Historical Context & Motivation

The quest to understand heredity at the molecular level began long before the iconic double helix graced the cover of Nature in 1953. Friedrich Miescher first isolated a phosphorus-rich substance from the nuclei of white blood cells in 1869, which he called nuclein — what we now recognize as DNA. For decades, most biochemists considered proteins, with their twenty distinct amino acids, to be the only molecules complex enough to carry genetic instructions. It was not until a series of elegant experiments in the mid-twentieth century that DNA was definitively established as the molecule of heredity, fundamentally reshaping our understanding of biology and disease.

The discovery of the double helix answered one critical question — how genetic information is stored — but opened many more. How is the helix unwound and copied with extraordinary fidelity before each cell division? What happens when the copying machinery makes a mistake, or when environmental agents damage the template? Understanding these processes is not merely an academic exercise: defects in DNA replication and DNA repair underlie numerous human diseases, from hereditary cancer syndromes to premature aging disorders, making this topic indispensable for future clinicians.

Core Principles of DNA Structure

DNA is a polymer of deoxyribonucleotides, each composed of three components: a five-carbon deoxyribose sugar, a phosphate group, and one of four nitrogenous bases. The two purine bases — adenine (A) and guanine (G) — contain a fused bicyclic ring, while the two pyrimidine bases — cytosine (C) and thymine (T) — have a single ring. The sugar-phosphate backbone runs in an antiparallel fashion: one strand extends 5′ → 3′ while its complement runs 3′ → 5′, and this directionality has profound implications for replication enzymology.

Visual Explanation: DNA Double Helix & Nucleotide Structure

Examine the diagram carefully. On the left, the two sugar-phosphate backbones (cyan and pink) twist around a common axis, with dashed horizontal lines representing the hydrogen bonds between complementary base pairs. The 5′ → 3′ polarity of the left strand runs top-to-bottom, while the right strand runs bottom-to-top, illustrating the antiparallel nature of DNA. On the right panel, each nucleotide is deconstructed into its three building blocks. A critical clinical point emerges from the sugar component: deoxyribose lacks a hydroxyl group at the 2′ position, which renders DNA more resistant to alkaline hydrolysis than RNA — a distinction that matters when interpreting molecular assays in the clinical laboratory.

DNA Replication Machinery

DNA replication in eukaryotes is a semiconservative process, as demonstrated by the classic Meselson–Stahl experiment using heavy nitrogen (¹⁵N) labeling. Each daughter duplex retains one parental strand and one newly synthesized strand. Replication begins at origins of replication (multiple in eukaryotes, single in prokaryotes), where the enzyme helicase unwinds the double helix, creating a replication fork. Single-stranded binding proteins (SSBs) stabilize the separated strands, while topoisomerase relieves the torsional strain ahead of the fork. Since all DNA polymerases synthesize in the 5′ → 3′ direction, the leading strand is synthesized continuously, while the lagging strand is synthesized discontinuously as short Okazaki fragments (~100–200 nucleotides in eukaryotes, ~1000–2000 in prokaryotes).

Key Enzymes at the Replication Fork

A common USMLE concept involves the end-replication problem. Because primase lays an RNA primer at the 5′ end of each Okazaki fragment, removal of the final primer on the lagging strand leaves an unrepaired gap that cannot be filled by any conventional DNA polymerase. With each cell division, telomeres shorten by approximately 50–200 base pairs. In somatic cells, progressive telomere attrition eventually triggers replicative senescence or apoptosis via p53-dependent pathways. Telomerase — active in germ cells, stem cells, and most cancer cells — mitigates this problem by adding TTAGGG repeats using an intrinsic RNA template, a concept classically tested on boards.

DNA Repair Pathways & Clinical Correlations

Despite the remarkable fidelity of replication, the human genome sustains an estimated 10,000–100,000 DNA lesions per cell per day from endogenous sources (reactive oxygen species, spontaneous depurination, deamination) and exogenous agents (UV radiation, alkylating chemotherapeutics, tobacco carcinogens). Multiple DNA repair pathways have evolved to identify and correct these lesions. Defects in these pathways are directly linked to cancer predisposition syndromes and are extensively tested on USMLE Step 1.

Pathway Details

Base Excision Repair (BER) addresses small, non-helix-distorting lesions such as oxidized bases (8-oxoguanine), deaminated bases (uracil from cytosine deamination), or alkylated bases. A specific DNA glycosylase recognizes and cleaves the damaged base, creating an abasic (AP) site. An AP endonuclease then nicks the backbone, and the gap is filled by DNA polymerase β and sealed by DNA ligase III. A frequently tested concept: spontaneous deamination of cytosine produces uracil, which is recognized and removed by uracil-DNA glycosylase. However, deamination of 5-methylcytosine yields thymine — a normal base — making this lesion harder to detect and explaining why CpG dinucleotides are mutational hotspots.

Nucleotide Excision Repair (NER) corrects bulky, helix-distorting lesions such as pyrimidine dimers caused by UV-B radiation (cyclobutane pyrimidine dimers and 6-4 photoproducts) and benzo[a]pyrene adducts from cigarette smoke. A multiprotein complex recognizes the distortion, excises a 24–32 nucleotide oligomer containing the lesion, and DNA polymerase and ligase fill and seal the gap. Defects in NER cause xeroderma pigmentosum (XP), an autosomal recessive disorder conferring a >1000-fold increased risk of skin cancer. Patients must avoid all UV exposure — a classic clinical vignette on boards.

Mismatch Repair (MMR) corrects base–base mismatches and insertion/deletion loops that escape proofreading during replication. The key proteins are MSH2 (mismatch recognition) and MLH1 (coordinates excision). In prokaryotes, the parental strand is distinguished from the daughter strand by methylation of GATC sequences (the newly synthesized strand is transiently unmethylated). In eukaryotes, the mechanism of strand discrimination likely involves recognition of nicks in the nascent strand. Germline mutations in MMR genes cause Lynch syndrome (HNPCC), an autosomal dominant condition that predisposes to colorectal, endometrial, and ovarian cancers. Tumors show microsatellite instability (MSI) — expansion or contraction of short tandem repeat sequences — a hallmark tested both clinically and on examinations.

Double-strand breaks (DSBs) are the most lethal form of DNA damage and are repaired by two primary pathways. Nonhomologous end joining (NHEJ) operates throughout the cell cycle and directly ligates broken ends using the Ku70/Ku80 heterodimer and DNA-PKcs, though it is error-prone and may introduce small insertions or deletions. Homologous recombination (HR) is active only in S and G2 phases when a sister chromatid is available as a template, making it high-fidelity. BRCA1 and BRCA2 are essential for HR; loss-of-function mutations render cells dependent on alternative, error-prone repair pathways. This vulnerability is exploited clinically through PARP inhibitors (e.g., olaparib), which block single-strand break repair, forcing cells into HR — a lethal event in BRCA-deficient cells (synthetic lethality).

Worked Example: Clinical Vignette Analysis

USMLE Step 1 frequently tests DNA repair through clinical vignettes. Let us walk through a representative question systematically.

Pharmacological Targeting of Replication & Repair

Many clinically important drugs exploit the replication and repair machinery as therapeutic targets. Understanding these connections is essential for both pharmacology and biochemistry sections of the USMLE. The table below organizes the major drug classes by their molecular targets within the replication and repair framework.

Connections to Advanced Concepts: Epigenetics & Genomic Instability

The principles of DNA structure, replication, and repair form the foundation for several advanced topics you will encounter in pathology, oncology, and pharmacology. Epigenetic modifications — heritable changes in gene expression that do not alter the DNA sequence itself — operate directly on DNA structure. DNA methyltransferases add methyl groups to cytosine at CpG dinucleotides, converting cytosine to 5-methylcytosine. Hypermethylation of tumor suppressor gene promoters is a common mechanism of gene silencing in cancer, functionally equivalent to a loss-of-function mutation. Conversely, global hypomethylation may activate oncogenes and promote genomic instability.

As you progress through pathology and pharmacology, you will see these repair pathways reappear in the context of cancer biology, immunology, and targeted therapeutics. The shift from understanding how DNA is repaired to understanding what happens when repair fails — genomic instability, clonal evolution, and therapeutic vulnerability — represents one of the most clinically relevant bridges in all of molecular medicine.

Practice Problems

Lesson Summary